DMAC

DMAC Operating Expenses

$38.86MTTM · USD

Period ending:

DMAC FY Operating ExpensesUSD
DMAC FY Operating Expenses2004-12-31: $637.31K2005-12-31: $228.69K2006-12-31: $812.95K2007-12-31: $2.47M2008-12-31: $1.69M2009-12-31: $2.40M2010-12-31: $3.84M2011-12-31: $6.71M2012-12-31: $10.11M2013-12-31: $7.43M2014-12-31: $4.83M2015-12-31: $1.31M2016-12-31: $2.48M2017-12-31: $4.28M2018-12-31: $7.26M2019-12-31: $11.59M2020-12-31: $12.70M2021-12-31: $13.65M2022-12-31: $14.00M2023-12-31: $21.27M2024-12-31: $26.68M2025-12-31: $34.40M$34.40M$0.00
2004-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

DMAC operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 22 observations from Dec 31, 2004 to Dec 31, 2025.

Diamedica Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
34,397,000
26,681,000
21,267,000
14,001,000
13,646,000
12,699,000
11,593,000
7,261,000
4,275,000
2,481,460
1,309,427
4,833,925
7,427,254
10,105,897
6,708,945
3,843,439
2,400,299
1,685,212
2,470,461
812,948
228,686
637,314

Compare operating expenses

All DMAC financial metrics · DMAC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.